Home
>
US Stocks
>
Bolt Biotherapeutics Inc
Bolt Biotherapeutics Inc
BOLT

Bolt Biotherapeutics Inc (BOLT)

$1317.46%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
13.28
Today Low/High
12.98 / 13.28
52 Week Low/High
$10.75 / $43.07
Market Cap
$476.92M

Company Details

Bolt Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Bolt’s proprietary Boltbody™ Immune-stimulating Antibody Conjugate (ISAC) approach combines an antibody that targets a tumor antigen with an immune stimulant that triggers an innate and adaptive immune response in the tumor microenvironment. These systemically-delivered Boltbody ISACs are designed to target tumor cells for elimination by myeloid cells, which are then activated and recruit the adaptive immune system in the anti-tumor response. This leads to the conversion of immunologically “cold” tumors to “hot” tumors. Bolt’s lead candidate, BDC-1001, is a Boltbody ISAC comprised of a HER2-targeting biosimilar of trastuzumab conjugated with a non-cleavable linker to one of Bolt’s proprietary TLR7/8 agonists for the treatment of patients with HER2-expressing solid tumors. Bolt is also advancing BDC-2034, a Boltbody ISAC targeting CEA, and a pipeline of other immuno-oncology products.
Organisation
Bolt Biotherapeutics Inc
Headquaters
Redwood City, California, US
Employees
65

Discover more

Frequently Asked Questions

What is Bolt Biotherapeutics Inc (BOLT) share price today?

Can Indians buy Bolt Biotherapeutics Inc (BOLT) shares?

How can I buy Bolt Biotherapeutics Inc (BOLT) shares from India?

Can Fractional shares of Bolt Biotherapeutics Inc (BOLT) be purchased?

What are the documents required to start investing in Bolt Biotherapeutics Inc (BOLT) stocks?

We are a SEBI registered investement advisor